3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Solitary Pulmonary Nodule
1
Multiple Pulmonary Nodules
1
Barrett Esophagus
1
Adenocarcinoma
1
Interventions
Gemcitabine
22
Fluorouracil
14
Oxaliplatin
13
Capecitabine
13
Paclitaxel
12
pembrolizumab
11
Cisplatin
11
Carboplatin
11
Pemetrexed
10
Leucovorin
9
130-nm albumin-bound paclitaxel
9
Ramucirumab
8
zolbetuximab
7
Albumin-Bound Paclitaxel
7
trastuzumab deruxtecan
6
Drug Therapy
5
Docetaxel
5
Bevacizumab
5
Nivolumab
4
Irinotecan
4
vandetanib
3
cemiplimab
3
Everolimus
3
EC145
3
tislelizumab
2
technetium 99m etarfolatide
2
spartalizumab
2
pralsetinib
2
osimertinib
2
nimotuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Adenocarcinoma
×
Diagnostic Imaging
×
Clear all
NCT00795184
2016-05-03
DONTBIOPCE
Mauna Kea Technologies
Phase NA
Completed
122 enrolled
5 charts